We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INNV icon
3426
InnovAge Holding
INNV
$1.52B
$659 ﹤0.01%
127
+72
+131% +$378
MSB
3427
Mesabi Trust
MSB
$306M
$655 ﹤0.01%
17
-13
-43% -$440
CFFI icon
3428
C&F Financial
CFFI
$286M
$653 ﹤0.01%
9
-1
-10% -$70
MVIS icon
3429
Microvision
MVIS
$78.9M
$652 ﹤0.01%
+52
New +$829
HNGE
3430
Hinge Health
HNGE
$7.21B
$650 ﹤0.01%
+14
New +$674
NXDR
3431
Nextdoor Holdings
NXDR
$986M
$643 ﹤0.01%
+306
New +$600
AOUT icon
3432
American Outdoor Brands
AOUT
$157M
$642 ﹤0.01%
83
+69
+493% +$512
PLX icon
3433
Protalix BioTherapeutics
PLX
$198M
$639 ﹤0.01%
+355
New +$726
TRTX
3434
TPG RE Finance Trust
TRTX
$618M
$629 ﹤0.01%
73
+34
+87% +$302
ADXN
3435
Addex Therapeutics
ADXN
$625 ﹤0.01%
81
-40
-33% -$343
RSVR
3436
Reservoir Media
RSVR
$667M
$621 ﹤0.01%
82
TECX
3437
Tectonic Therapeutic
TECX
$606M
$605 ﹤0.01%
29
+21
+263% +$390
EVO icon
3438
Evotec
EVO
$711M
$604 ﹤0.01%
196
-1,693
-90% -$5.81K
AISP
3439
Airship AI Holdings
AISP
$71.3M
$601 ﹤0.01%
+208
New +$857
GERN icon
3440
Geron
GERN
$949M
$593 ﹤0.01%
+449
New +$563
CBNK icon
3441
Capital Bancorp
CBNK
$615M
$592 ﹤0.01%
21
-20
-49% -$574
RXT icon
3442
Rackspace Technology
RXT
$1.24B
$592 ﹤0.01%
+610
New +$768
CHRS icon
3443
Coherus Oncology
CHRS
$196M
$578 ﹤0.01%
+407
New +$593
RMBI icon
3444
Richmond Mutual Bancorp
RMBI
$254M
$576 ﹤0.01%
41
-34
-45% -$466
STLN
3445
Starling Oncology, Inc. Common Stock
STLN
$641M
$570 ﹤0.01%
+160
New +$593
ACIC icon
3446
American Coastal Insurance
ACIC
$493M
$568 ﹤0.01%
45
CRD.A icon
3447
Crawford & Co Class A
CRD.A
$669M
$563 ﹤0.01%
50
IGLB icon
3448
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
$555 ﹤0.01%
11
OMDA
3449
Omada Health Inc
OMDA
$1.41B
$552 ﹤0.01%
+35
New +$710
FTK icon
3450
Flotek Industries
FTK
$1.28B
$551 ﹤0.01%
+32
New +$508

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.